New York, NY -- (SBWIRE) -- 04/29/2020 -- Latest research findings from Market Industry Reports (MIR) report titled "Hydroxychloroquine Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030." Suggests that the global hydroxychloroquine market is expected to witness substantial CAGR from 2020 to 2030.?

The market growth can be attributed to several factors, which has led toits wide-scale adoption. Growing prevalence of malaria and increasing demand of hydroxychloroquine drug worldwide for the treatment of COVID-19are anticipated to fuel its demand. However, restrictions on its purchase ever since it has been considered for the treatment of newly discovered disease COVID-19 is likely to restrain the market growth to a certain extent.

Some of the prominent players operating in the hydroxychloroquine market are Sanofi, Novartis AG, Ipca Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Zydus Cadila, Lupin Pharmaceuticals, Inc., DR. REDDY'S LABORATORIES LTD., Bristol Laboratories Ltd, Mylan N.V., Teva Pharmaceuticals USA, Inc., among others.

Get sample copy of the report (for quick response, use the provided business email id) @ https://www.marketindustryreports.com/pdf/306

According to WHO, in 2018, nearly half of the world's population was at risk of malaria and there were 228 million cases of malaria in 2018 as compared to 231 million cases in 2017. The estimated number of malaria deaths was 405,000 in 2018, as compared to 416 000 deaths in 2017.Incessantly rising prevalence of malaria is expected to boost the market growth.

Hydroxychloroquine has been identified by the US Food and Drug Administration as a possible treatment for the COVID-19(though not proven clinically yet). This has led to precipitous demand of hydroxychloroquine as a preventive measure against COVID-19. For instance, in April 2020, The President of the United States of America endorsed the use of this drug as preventive measure and requested India, a major manufacturer of hydroxychloroquine to partially lift the ban on the export of the drug.

Asia Pacific(APAC) dominates the hydroxychloroquine market. The growth of the Asia Pacific market can be attributed to the presence of prominent players, which produce about 70% of overall world capacity of hydroxychloroquine. Countries in the APAC region such as India and China are anticipated to provide significant growth opportunities to the stakeholders owing to the presence of manufacturers of active pharmaceutical ingredients (APIs) and hydroxychloroquine formulation.

Click here for Interesting Discount @ https://www.marketindustryreports.com/discount/306

Segmentation Occured By Type:
200mg and 400mg

Segmentation Occured By Application:
Rheumatoid Arthritis, Malaria, COVID-19 and Lupus

Table of Contents

1.INTRODUCTION
Market Definition
Market Classification
Geographic Scope
Years Considered for the Study: Historical Years - 2017 & 2018; Base Year - 2019; Forecast Years - 2020 to 2030
Currency Used

2.RESEARCH METHODOLOGY
Research Framework
Data Collection Technique
Data Sources
Secondary Sources
Primary Sources
Market Estimation Methodology
Bottom Up Approach
Top Down Approach
Data Validation and Triangulation
Market Forecast Model
Limitations/Assumptions of the Study

3.ABSTRACT OF THE STUDY

4.MARKET DYNAMICS ASSESSMENT
Overview
Drivers
Barriers/Challenges
Opportunities

To Be Continues........

Buy Full Research Report @ https://www.marketindustryreports.com/checkout/306

About Market Industry Reports:

Market Industry Reports is a global leader in market measurement & advisory services, Market Industry Reports is at the forefront of innovation to address the worldwide industry trends and opportunities. We identified the caliber of market dynamics & hence we excel in the areas of innovation and optimization, integrity, curiosity, customer and brand experience, and strategic business intelligence through our research.

Contact Us:

Phone: + 91 8956767535
Email: sales@marketindustryreports.com
Website: www.marketindustryreports.com